MHLW To Establish Research Team On Tamiflu-Resistant Flu Virus
This article was originally published in PharmAsia News
Japan's Ministry of Health, Labor and Welfare decided to establish a emergency research team to inspect national Tamiflu (oseltamivir) resistant flu virus cases; Japan is the biggest consumer nation for Tamiflu. Japan's National Infectious Diseases Institute has seen recent reports from Miyagi and Shiga Prefectures where Tamiflu-resistant flu virus was found among children. In Europe and the U.S., such reports have been increasing recently. To prepare for a potential spread of such a virus, the MHLW team aims to establish treatment policy guidelines for the virus and gather information on group infection routes and Tamiflu administration. (Click here for more - Japanese language
You may also be interested in...
The Belgian biotech has managed to attract considerable sums from venture capitalists over the past couple of years amid hopes that its two next-generation immunotherapies will be best-in-class agents.
Cipla is celebrating an “important milestone” for the company after the successful completion of a Phase III clinical trial comparing its proposed Advair generic with GSK’s brand in the US. Management has cautioned that approval will be a way off yet, however.
FDA requests immediate removal of ranitidine OTC and Rx drugs after third-party testing finds contaminant NDMA increases during storage, especially at higher temperatures. CDER Director Janet Woodcock asks firms to reformulate products to be stable as the ingredient remains approved.